Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption.
Fretheim
A
A
D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening / Q000191:economics*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis*